ARTICLE | Clinical News
NT-501: Phase II data
June 1, 2009 7:00 AM UTC
Data from a double-blind Phase II trial in 67 patients with early stage RP showed that the high dose NT-501 implant led to a dose-dependent increase in retinal thickness from baseline to month 12 (p<0...